60 Degrees Pharmaceuticals Inc. (SXTP) Net Asset Value

This daily price action for 60 Degrees Pharmaceuticals (SXTP) on GURU.Markets is recorded at -0.01. 60 Degrees Pharmaceuticals generates revenue by supplying anti-malarial and tropical disease treatments to government agencies and pharmacies. Drug development relies on bioinformatics software that eliminates manual labor during testing. Business resilience is guaranteed by a cohesive team of scientists whose competencies are protected by long-term assets.

To assess the resilience of 60 Degrees Pharmaceuticals (SXTP) to market downturns, analyzing available resources is critical, as a biotech startup in the early stages of commercialization is heavily dependent on external financing. This balance sheet capitalization chart captures the volume of net assets minus liabilities, allowing investors to track capital preservation trends amid operational deficits and evaluate the business's actual financial autonomy.